Nexium
Sponsors
Mayo Clinic, AstraZeneca, University of Utah, Lise Tarnow, Effexus Pharmaceutical
Conditions
Acid DyspepsiaExercise Triggered AsthmaGERDGastritisGastroesophageal RefluxGastroesophageal Reflux Disease (GERD)HealthyHeartburn
Phase 1
Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
TerminatedNCT00444236
Start: 2007-04-30End: 2009-09-30Updated: 2016-01-21
Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.
NCT01129713
Start: 2010-05-31End: 2015-05-31Target: 40Updated: 2014-08-05
The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects
CompletedNCT01921647
Start: 2013-07-31End: 2013-11-30Updated: 2013-12-03
A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects
CompletedNCT03211143
Start: 2017-06-20End: 2017-08-28Updated: 2017-11-21
PK/PD Clinical Trial of YYD601 in Healthy Adult Male
CompletedNCT03558477
Start: 2017-09-19End: 2018-02-07Updated: 2018-06-15
Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France)
CompletedNCT05038969
Start: 2021-03-18End: 2021-05-28Updated: 2021-09-09
Phase 2
Phase 3
Phase 4
Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects
CompletedNCT00230516
Start: 2005-09-30End: 2006-02-28Target: 100Updated: 2013-01-04
Bioequivalence of Two Formulations of Esomeprazole
CompletedNCT02543606
Start: 2015-04-30End: 2015-06-30Updated: 2015-09-07
Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
CompletedNCT02711176
Start: 2016-09-30End: 2017-03-27Updated: 2017-06-08
Unknown Phase
Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy
CompletedNCT00170001
Start: 2005-04-30End: 2006-08-31Updated: 2011-12-15
Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication
CompletedNCT02596620
Start: 2013-10-31End: 2015-11-30Updated: 2017-02-28
Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy
CompletedNCT03383003
Start: 2016-03-01End: 2018-05-01Updated: 2019-01-30